Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTC-510 and NTC-510A for Dental Pain
NCT02161354Phase 2Terminated
- Sponsor
- Nanoshift
- Start
- Jun 2014
- Primary completion
- Feb 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of buprenorphine in toothache, sponsored by Nanoshift. Started Jun 2014; status: terminated.
02
Drugs
buprenorphine
03
Conditions
toothache
Beyond the preview
Go deeper on NCT02161354.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02161354.